ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer
- 1 June 2023
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 83 (6), 508-518
- https://doi.org/10.1016/j.eururo.2022.09.009
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysisEuropean Urology, 2016
- Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant StudyJournal of Clinical Oncology, 2014
- Metastases in Normal-sized Pelvic Lymph Nodes: Detection with Diffusion-weighted MR ImagingRadiology, 2014
- Targeted Androgen Pathway Suppression in Localized Prostate Cancer: A Pilot StudyJournal of Clinical Oncology, 2014
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate CancerCancer Cell, 2011
- A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinomaCancer Treatment Reviews, 2009
- Prognostic Significance of Disseminated Tumor Cells in the Bone Marrow of Prostate Cancer Patients Treated With Neoadjuvant Hormone TreatmentJournal of Clinical Oncology, 2008
- Changing Nature of High Risk Patients Undergoing Radical ProstatectomyJournal of Urology, 2007
- Cross-sectional imaging of nodal metastases in the abdomen and pelvisAbdominal Radiology, 2006
- Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancerThe Prostate, 2001